ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W107. A total of 40 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $5,000 | +66.7% | 14,000 | 0.0% | 0.00% | – |
Q1 2020 | $3,000 | 0.0% | 14,000 | 0.0% | 0.00% | – |
Q4 2019 | $3,000 | -94.6% | 14,000 | -94.3% | 0.00% | -100.0% |
Q3 2019 | $56,000 | -3.4% | 245,281 | +3.8% | 0.00% | 0.0% |
Q2 2019 | $58,000 | -31.0% | 236,281 | +34.6% | 0.00% | 0.0% |
Q1 2019 | $84,000 | +110.0% | 175,512 | +69.3% | 0.00% | +100.0% |
Q4 2018 | $40,000 | -54.0% | 103,672 | -12.4% | 0.00% | -50.0% |
Q3 2018 | $87,000 | +85.1% | 118,300 | +60.8% | 0.00% | +100.0% |
Q2 2018 | $47,000 | – | 73,552 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 1,590,267 | $915,000 | 0.48% |
ARMISTICE CAPITAL, LLC | 4,382,000 | $2,520,000 | 0.30% |
DAFNA Capital Management LLC | 333,000 | $192,000 | 0.12% |
SABBY MANAGEMENT, LLC | 2,434,103 | $1,400,000 | 0.09% |
Anson Funds Management LP | 1,024,592 | $589,000 | 0.09% |
Hartford Financial Management Inc. | 18,000 | $10,000 | 0.01% |
Summit X, LLC | 11,000 | $7,000 | 0.01% |
SNS Financial Group, LLC | 18,000 | $10,000 | 0.00% |
DOWLING & YAHNKE LLC | 22,870 | $13,000 | 0.00% |
A.R.T. Advisors, LLC | 30,005 | $17,000 | 0.00% |